Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym.Unit - manually
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asym.Unit - manually
Asym.Unit - manually  (Jmol Viewer)
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF MURINE OX40L BOUND TO HUMAN OX40
 
Authors :  S. G. Hymowitz
Date :  22 Jun 06  (Deposition) - 29 Aug 06  (Release) - 13 Jul 11  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  2.00
Chains :  Asym. Unit :  F,G,R,T
Biol. Unit 1:  F,R  (3x)
Biol. Unit 2:  G,T  (3x)
Keywords :  Cytokine, Receptor-Ligan Complex, Co-Stimulator, Tnfsf (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  D. M. Compaan, S. G. Hymowitz
The Crystal Structure Of The Costimulatory Ox40-Ox40L Complex.
Structure V. 14 1321 2006
PubMed-ID: 16905106  |  Reference-DOI: 10.1016/J.STR.2006.06.015

(-) Compounds

Molecule 1 - TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 4
    ChainsF, G
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System CommonFALL ARMYWORM
    Expression System StrainHI5
    Expression System Taxid7108
    FragmentEXTRACELLULAR DOMAIN (RESIDUES 51-198)
    GeneTNFSF4, OX40L, TXGP1L
    Organism CommonHOUSE MOUSE
    Organism ScientificMUS MUSCULUS
    Organism Taxid10090
    SynonymOX40 LIGAND, OX40L, CD252 ANTIGEN
 
Molecule 2 - TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 4
    ChainsR, T
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System CommonFALL ARMYWORM
    Expression System StrainHI5
    Expression System Taxid7108
    FragmentEXTRACELLULAR DOMAIN (RESIDUES 29-170)
    GeneTNFRSF4, TXGP1L
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymOX40L RECEPTOR, ACT35 ANTIGEN, TAX TRANSCRIPTIONALLY- ACTIVATED GLYCOPROTEIN 1 RECEPTOR, CD134 ANTIGEN

 Structural Features

(-) Chains, Units

  1234
Asymmetric Unit FGRT
Biological Unit 1 (3x)F R 
Biological Unit 2 (3x) G T

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 1)

Asymmetric Unit (1, 1)
No.NameCountTypeFull Name
1SO41Ligand/IonSULFATE ION
Biological Unit 1 (1, 3)
No.NameCountTypeFull Name
1SO43Ligand/IonSULFATE ION
Biological Unit 2 (0, 0)
No.NameCountTypeFull Name
1SO4-1Ligand/IonSULFATE ION

(-) Sites  (1, 1)

Asymmetric Unit (1, 1)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREARG R:41 , CYS R:43 , HIS R:44 , ARG R:47 , ASN R:61 , THR R:62 , HOH R:178BINDING SITE FOR RESIDUE SO4 R 171

(-) SS Bonds  (19, 19)

Asymmetric Unit
No.Residues
1F:70 -F:163
2F:98 -F:183
3G:70 -G:163
4G:98 -G:183
5R:31 -R:42
6R:43 -R:56
7R:46 -R:64
8R:67 -R:81
9R:84 -R:99
10R:87 -R:107
11R:109 -R:125
12R:128 -R:141
13T:31 -T:42
14T:43 -T:56
15T:46 -T:64
16T:67 -T:81
17T:84 -T:99
18T:87 -T:107
19T:109 -T:125

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2HEY)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (1, 2)

Asymmetric Unit (1, 2)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_070942R65CTNR4_HUMANDisease (IMD16)587777075R/TR65C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (1, 3)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_070942R65CTNR4_HUMANDisease (IMD16)587777075RR65C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (1, 3)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_070942R65CTNR4_HUMANDisease (IMD16)587777075TR65C

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (3, 10)

Asymmetric Unit (3, 10)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1TNFR_NGFR_2PS50050 TNFR/NGFR family cysteine-rich region domain profile.TNR4_HUMAN30-64
 
66-107
 
  4R:30-64
T:30-64
R:66-107
T:66-107
2TNFR_NGFR_1PS00652 TNFR/NGFR family cysteine-rich region signature.TNR4_HUMAN31-64
 
64-107
 
  4R:31-64
T:31-64
R:64-107
T:64-107
3TNF_1PS00251 TNF family signature.TNFL4_MOUSE94-110
 
  2F:94-110
G:94-110
Biological Unit 1 (3, 15)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1TNFR_NGFR_2PS50050 TNFR/NGFR family cysteine-rich region domain profile.TNR4_HUMAN30-64
 
66-107
 
  6R:30-64
-
R:66-107
-
2TNFR_NGFR_1PS00652 TNFR/NGFR family cysteine-rich region signature.TNR4_HUMAN31-64
 
64-107
 
  6R:31-64
-
R:64-107
-
3TNF_1PS00251 TNF family signature.TNFL4_MOUSE94-110
 
  3F:94-110
-
Biological Unit 2 (3, 15)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1TNFR_NGFR_2PS50050 TNFR/NGFR family cysteine-rich region domain profile.TNR4_HUMAN30-64
 
66-107
 
  6-
T:30-64
-
T:66-107
2TNFR_NGFR_1PS00652 TNFR/NGFR family cysteine-rich region signature.TNR4_HUMAN31-64
 
64-107
 
  6-
T:31-64
-
T:64-107
3TNF_1PS00251 TNF family signature.TNFL4_MOUSE94-110
 
  3-
G:94-110

(-) Exons   (5, 10)

Asymmetric Unit (5, 10)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1bENST000003792361bENSE00001832731chr1:1149512-1149363150TNR4_HUMAN1-49492R:29-49
T:29-49
21
21
1.2aENST000003792362aENSE00001333068chr1:1149165-1149043123TNR4_HUMAN49-90422R:49-90
T:49-90
42
42
1.2eENST000003792362eENSE00001333064chr1:1148473-1148372102TNR4_HUMAN90-124352R:90-124
T:90-124
35
35
1.3ENST000003792363ENSE00001333060chr1:1148084-114801867TNR4_HUMAN124-146232R:124-146
T:124-146
23
23
1.4bENST000003792364bENSE00001545401chr1:1147518-1147322197TNR4_HUMAN146-212672R:146-166
T:146-166 (gaps)
21
21
1.5aENST000003792365aENSE00001333051chr1:1147212-1147084129TNR4_HUMAN212-255440--
1.5dENST000003792365dENSE00001915458chr1:1147005-1146706300TNR4_HUMAN255-277230--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain F from PDB  Type:PROTEIN  Length:135
 aligned with TNFL4_MOUSE | P43488 from UniProtKB/Swiss-Prot  Length:198

    Alignment length:135
                                    66        76        86        96       106       116       126       136       146       156       166       176       186     
          TNFL4_MOUSE    57 DPPIQRLRGAVTRCEDGQLFISSYKNEYQTMEVQNNSVVIKCDGLYIIYLKGSFFQEVKIDLHFREDHNPISIPMLNDGRRIVFTVVASLAFKDKVYLTVNAPDTLCEHLQINDGELIVVQLTPGYCAPEGSYHS 191
               SCOP domains d2heyf_ F: Tumor necrosis factor ligand superfamily member 4, OX40L                                                                     SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeeeeeeee..eeeeee.........ee..eee....eeeeeeeeee......eeee.......eee.......eeeeeeeeee....eeeeee..hhhhhhhh..eeeeeeeee.............. Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) -------------------------------------TNF_1            --------------------------------------------------------------------------------- PROSITE (2)
                 Transcript --------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 2hey F  57 DPPIQRLRGAVTRCEDGQLFISSYKNEYQTMEVQNNSVVIKCDGLYIIYLKGSFFQEVKIDLHFREDHNPISIPMLNDGRRIVFTVVASLAFKDKVYLTVNAPDTLCEHLQINDGELIVVQLTPGYCAPEGSYHS 191
                                    66        76        86        96       106       116       126       136       146       156       166       176       186     

Chain G from PDB  Type:PROTEIN  Length:134
 aligned with TNFL4_MOUSE | P43488 from UniProtKB/Swiss-Prot  Length:198

    Alignment length:134
                                    66        76        86        96       106       116       126       136       146       156       166       176       186    
          TNFL4_MOUSE    57 DPPIQRLRGAVTRCEDGQLFISSYKNEYQTMEVQNNSVVIKCDGLYIIYLKGSFFQEVKIDLHFREDHNPISIPMLNDGRRIVFTVVASLAFKDKVYLTVNAPDTLCEHLQINDGELIVVQLTPGYCAPEGSYH 190
               SCOP domains d2heyg_ G: Tumor necrosis factor ligand superfamily member 4, OX40L                                                                    SCOP domains
               CATH domains -------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains -------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .....eeeeeeeeee..eeeeee.........ee..eee....eeeeeeeeeee.....eeee.......ee........eeeeeeeeee....eeeeee..hhhhhhh..eeeeeeeeee............. Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (2) -------------------------------------TNF_1            -------------------------------------------------------------------------------- PROSITE (2)
                 Transcript -------------------------------------------------------------------------------------------------------------------------------------- Transcript
                 2hey G  57 DPPIQRLRGAVTRCEDGQLFISSYKNEYQTMEVQNNSVVIKCDGLYIIYLKGSFFQEVKIDLHFREDHNPISIPMLNDGRRIVFTVVASLAFKDKVYLTVNAPDTLCEHLQINDGELIVVQLTPGYCAPEGSYH 190
                                    66        76        86        96       106       116       126       136       146       156       166       176       186    

Chain R from PDB  Type:PROTEIN  Length:138
 aligned with TNR4_HUMAN | P43489 from UniProtKB/Swiss-Prot  Length:277

    Alignment length:138
                                    38        48        58        68        78        88        98       108       118       128       138       148       158        
           TNR4_HUMAN    29 LHCVGDTYPSNDRCCHECRPGNGMVSRCSRSQNTVCRPCGPGFYNDVVSSKPCKPCTWCNLRSGSERKQLCTATQDTVCRCRAGTQPLDSYKPGVDCAPCPPGHFSPGDNQACKPWTNCTLAGKHTLQPASNSSDAIC 166
               SCOP domains d2heyr3 R:29-82                                       d2heyr1 R:83-142                                            d2heyr2 R:143-166        SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ......eeee..eeee.....eeeee........eeee....ee.........ee....hhhh.eeeee........eeee...eee.........eee....ee........ee....................... Sec.struct. author
                 SAPs(SNPs) ------------------------------------C----------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) -TNFR_NGFR_2  PDB: R:30-64          -TNFR_NGFR_2  PDB: R:66-107 UniProt: 66-107----------------------------------------------------------- PROSITE (1)
                PROSITE (2) --TNFR_NGFR_1  PDB: R:31-64         ------------------------------------------------------------------------------------------------------ PROSITE (2)
                PROSITE (3) -----------------------------------TNFR_NGFR_1  PDB: R:64-107 UniProt: 64-107  ----------------------------------------------------------- PROSITE (3)
           Transcript 1 (1) Exon 1.1b            ----------------------------------------Exon 1.2e  PDB: R:90-124           ---------------------Exon 1.4b             Transcript 1 (1)
           Transcript 1 (2) --------------------Exon 1.2a  PDB: R:49-90 UniProt: 49-90    ---------------------------------Exon 1.3  PDB: R:124-14-------------------- Transcript 1 (2)
                 2hey R  29 LHCVGDTYPSNDRCCHECRPGNGMVSRCSRSQNTVCRPCGPGFYNDVVSSKPCKPCTWCNLRSGSERKQLCTATQDTVCRCRAGTQPLDSYKPGVDCAPCPPGHFSPGDNQACKPWTNCTLAGKHTLQPASNSSDAIC 166
                                    38        48        58        68        78        88        98       108       118       128       138       148       158        

Chain T from PDB  Type:PROTEIN  Length:135
 aligned with TNR4_HUMAN | P43489 from UniProtKB/Swiss-Prot  Length:277

    Alignment length:138
                                    38        48        58        68        78        88        98       108       118       128       138       148       158        
           TNR4_HUMAN    29 LHCVGDTYPSNDRCCHECRPGNGMVSRCSRSQNTVCRPCGPGFYNDVVSSKPCKPCTWCNLRSGSERKQLCTATQDTVCRCRAGTQPLDSYKPGVDCAPCPPGHFSPGDNQACKPWTNCTLAGKHTLQPASNSSDAIC 166
               SCOP domains d2heyt3 T:29-82                                       d2heyt1 T:83-142                                            d2heyt2    T:143-166     SCOP domains
               CATH domains ------------------------------------------------------------------------------------------------------------------------------------------ CATH domains
               Pfam domains ------------------------------------------------------------------------------------------------------------------------------------------ Pfam domains
         Sec.struct. author ......eeee..eeee.....eeeee........eeee....ee.........ee.........eeeee........eeee...eee.........eee....ee........ee.......---............. Sec.struct. author
                 SAPs(SNPs) ------------------------------------C----------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) -TNFR_NGFR_2  PDB: T:30-64          -TNFR_NGFR_2  PDB: T:66-107 UniProt: 66-107----------------------------------------------------------- PROSITE (1)
                PROSITE (2) --TNFR_NGFR_1  PDB: T:31-64         ------------------------------------------------------------------------------------------------------ PROSITE (2)
                PROSITE (3) -----------------------------------TNFR_NGFR_1  PDB: T:64-107 UniProt: 64-107  ----------------------------------------------------------- PROSITE (3)
           Transcript 1 (1) Exon 1.1b            ----------------------------------------Exon 1.2e  PDB: T:90-124           ---------------------Exon 1.4b             Transcript 1 (1)
           Transcript 1 (2) --------------------Exon 1.2a  PDB: T:49-90 UniProt: 49-90    ---------------------------------Exon 1.3  PDB: T:124-14-------------------- Transcript 1 (2)
                 2hey T  29 LHCVGDTYPSNDRCCHECRPGNGMVSRCSRSQNTVCRPCGPGFYNDVVSSKPCKPCTWCNLRSGSERKQLCTATQDTVCRCRAGTQPLDSYKPGVDCAPCPPGHFSPGDNQACKPWTNCTLA---TLQPASNSSDAIC 166
                                    38        48        58        68        78        88        98       108       118       128       138       148 |   | 158        
                                                                                                                                                   150 154            

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (2, 8)

Asymmetric Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2HEY)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2HEY)

(-) Gene Ontology  (76, 85)

Asymmetric Unit(hide GO term definitions)
Chain F,G   (TNFL4_MOUSE | P43488)
molecular function
    GO:0005125    cytokine activity    Functions to control the survival, growth, differentiation and effector function of tissues and cells.
    GO:0005164    tumor necrosis factor receptor binding    Interacting selectively and non-covalently with the tumor necrosis factor receptor.
    GO:0032813    tumor necrosis factor receptor superfamily binding    Interacting selectively and non-covalently with any member of the tumor necrosis factor receptor superfamily.
biological process
    GO:0035783    CD4-positive, alpha-beta T cell costimulation    The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment CD4-positive, alpha-beta T cell activation.
    GO:0042098    T cell proliferation    The expansion of a T cell population by cell division. Follows T cell activation.
    GO:0035712    T-helper 2 cell activation    The change in morphology and behavior of a T helper 2 cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
    GO:0002526    acute inflammatory response    Inflammation which comprises a rapid, short-lived, relatively uniform response to acute injury or antigenic challenge and is characterized by accumulations of fluid, plasma proteins, and granulocytic leukocytes. An acute inflammatory response occurs within a matter of minutes or hours, and either resolves within a few days or becomes a chronic inflammatory response.
    GO:0001568    blood vessel development    The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood.
    GO:0071222    cellular response to lipopolysaccharide    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0035714    cellular response to nitrogen dioxide    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen dioxide (NO2) stimulus.
    GO:0071380    cellular response to prostaglandin E stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prostagladin E stimulus.
    GO:0071954    chemokine (C-C motif) ligand 11 production    The appearance of chemokine (C-C motif) ligand 11 (CCL11, also known as eotaxin-1) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
    GO:0008203    cholesterol metabolic process    The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues.
    GO:0001816    cytokine production    The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
    GO:0002215    defense response to nematode    A response to protect an organism from a directly detected or perceived external threat from a nematode or nematodes, which results in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0006954    inflammatory response    The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
    GO:0045087    innate immune response    Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
    GO:0035709    memory T cell activation    The change in morphology and behavior of a memory T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific.
    GO:0070233    negative regulation of T cell apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of T cell death by apoptotic process.
    GO:0045626    negative regulation of T-helper 1 cell differentiation    Any process that stops, prevents, or reduces the frequency, rate or extent of T-helper 1 cell differentiation.
    GO:0070236    negative regulation of activation-induced cell death of T cells    Any process that stops, prevents, or reduces the frequency, rate or extent of activation-induced cell death of T cells.
    GO:0050710    negative regulation of cytokine secretion    Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of cytokines from a cell.
    GO:2001237    negative regulation of extrinsic apoptotic signaling pathway    Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway.
    GO:0032689    negative regulation of interferon-gamma production    Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
    GO:0032700    negative regulation of interleukin-17 production    Any process that stops, prevents, or reduces the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
    GO:0045590    negative regulation of regulatory T cell differentiation    Any process that stops, prevents, or reduces the rate of differentiation of regulatory T cells.
    GO:0043433    negative regulation of sequence-specific DNA binding transcription factor activity    Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
    GO:0045892    negative regulation of transcription, DNA-templated    Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0050871    positive regulation of B cell activation    Any process that activates or increases the frequency, rate or extent of B cell activation.
    GO:1900281    positive regulation of CD4-positive, alpha-beta T cell costimulation    Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell costimulation.
    GO:0043372    positive regulation of CD4-positive, alpha-beta T cell differentiation    Any process that activates or increases the frequency, rate or extent of CD4-positive, alpha-beta T cell differentiation.
    GO:2000525    positive regulation of T cell costimulation    Any process that activates or increases the frequency, rate or extent of T cell costimulation.
    GO:0002726    positive regulation of T cell cytokine production    Any process that activates or increases the frequency, rate, or extent of T cell cytokine production.
    GO:2000406    positive regulation of T cell migration    Any process that activates or increases the frequency, rate or extent of T cell migration.
    GO:2000570    positive regulation of T-helper 2 cell activation    Any process that activates or increases the frequency, rate or extent of T-helper 2 cell activation.
    GO:0045630    positive regulation of T-helper 2 cell differentiation    Any process that activates or increases the frequency, rate or extent of T-helper 2 cell differentiation.
    GO:0042104    positive regulation of activated T cell proliferation    Any process that activates or increases the rate or extent of activated T cell proliferation.
    GO:0046641    positive regulation of alpha-beta T cell proliferation    Any process that activates or increases the frequency, rate or extent of alpha-beta T cell proliferation.
    GO:0002699    positive regulation of immune effector process    Any process that activates or increases the frequency, rate, or extent of an immune effector process.
    GO:0002891    positive regulation of immunoglobulin mediated immune response    Any process that activates or increases the frequency, rate, or extent of an immunoglobulin mediated immune response.
    GO:0051024    positive regulation of immunoglobulin secretion    Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
    GO:0050729    positive regulation of inflammatory response    Any process that activates or increases the frequency, rate or extent of the inflammatory response.
    GO:0032729    positive regulation of interferon-gamma production    Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
    GO:0032733    positive regulation of interleukin-10 production    Any process that activates or increases the frequency, rate, or extent of interleukin-10 production.
    GO:0032735    positive regulation of interleukin-12 production    Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
    GO:0032736    positive regulation of interleukin-13 production    Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
    GO:0032743    positive regulation of interleukin-2 production    Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.
    GO:0032753    positive regulation of interleukin-4 production    Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
    GO:2000572    positive regulation of interleukin-4-dependent isotype switching to IgE isotypes    Any process that activates or increases the frequency, rate or extent of interleukin-4-dependent isotype switching to IgE isotypes.
    GO:0032755    positive regulation of interleukin-6 production    Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
    GO:2000568    positive regulation of memory T cell activation    Any process that activates or increases the frequency, rate or extent of memory T cell activation.
    GO:0043382    positive regulation of memory T cell differentiation    Any process that activates or increases the frequency, rate or extent of memory T cell differentiation.
    GO:0002830    positive regulation of type 2 immune response    Any process that activates or increases the frequency, rate, or extent of a type 2 immune response.
    GO:0002819    regulation of adaptive immune response    Any process that modulates the frequency, rate, or extent of an adaptive immune response.
    GO:0050727    regulation of inflammatory response    Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents.
    GO:0035713    response to nitrogen dioxide    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen dioxide (NO2) stimulus.
    GO:0009615    response to virus    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
cellular component
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

Chain R,T   (TNR4_HUMAN | P43489)
molecular function
    GO:0005031    tumor necrosis factor-activated receptor activity    Combining with tumor necrosis factor, a proinflammatory cytokine produced by monocytes and macrophages, to initiate a change in cell function.
    GO:0001618    virus receptor activity    Combining with a virus component and mediating entry of the virus into the cell.
biological process
    GO:0042098    T cell proliferation    The expansion of a T cell population by cell division. Follows T cell activation.
    GO:0097190    apoptotic signaling pathway    A series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered.
    GO:0006955    immune response    Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat.
    GO:0006954    inflammatory response    The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0043433    negative regulation of sequence-specific DNA binding transcription factor activity    Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
    GO:0045892    negative regulation of transcription, DNA-templated    Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription.
    GO:0030890    positive regulation of B cell proliferation    Any process that activates or increases the rate or extent of B cell proliferation.
    GO:0043410    positive regulation of MAPK cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
    GO:0051024    positive regulation of immunoglobulin secretion    Any process that activates or increases the frequency, rate or extent of the regulated release of immunoglobulins from a cell.
    GO:0042981    regulation of apoptotic process    Any process that modulates the occurrence or rate of cell death by apoptotic process.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:0032496    response to lipopolysaccharide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0033209    tumor necrosis factor-mediated signaling pathway    A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0046718    viral entry into host cell    The process that occurs after viral attachment by which a virus, or viral nucleic acid, breaches the plasma membrane or cell envelope and enters the host cell. The process ends when the viral nucleic acid is released into the host cell cytoplasm.
    GO:0016032    viral process    A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle.
cellular component
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    SO4  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2hey)
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2hey
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  TNFL4_MOUSE | P43488
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
  TNR4_HUMAN | P43489
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  (no 'Enzyme Classificator' available)
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  615593
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  TNFL4_MOUSE | P43488
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)
  TNR4_HUMAN | P43489
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        TNFL4_MOUSE | P434882hew
        TNR4_HUMAN | P434891d0a 2hev

(-) Related Entries Specified in the PDB File

2hev 2hew